Here’s the heartbreaking news no Dallas Mavericks fan wanted to hear: Kyrie Irving won’t be returning this season. Yes, you read that right. The Mavs star, who’s been battling back from a devastating torn ACL since March 2025, has officially been ruled out for the remainder of the 2025-26 season. But here’s where it gets even more emotional—Irving himself shared that this decision, though difficult, was necessary for his long-term health and future success. In a statement, he vowed, ‘I am looking forward to coming back stronger next season.’ Bold words from a player who’s no stranger to adversity, but will his patience pay off? And this is the part most people miss: Irving’s absence isn’t just about his recovery—it’s a strategic move by the Mavs to secure a higher draft pick and rebuild for a championship run. Controversial? Maybe. But is it the right call? Let’s dive deeper.
The Mavericks announced on Wednesday (via NBA.com) that Irving has been making ‘steady progress’ in his rehab, but the focus is on ensuring he’s ‘1000%’ ready for next season. His agent, Shetellia Riley Irving, told ESPN’s Shams Charania (X.com) that this decision is all about maximizing his chances to chase a championship in 2026-27. Sounds logical, right? But here’s the kicker: Irving’s injury history has been a recurring theme since joining the Mavs in February 2023. In the 117 games he’s missed, the team has a dismal 42-75 record. That’s a stat that’s hard to ignore. So, while his absence might hurt now, could it be the best move for the franchise’s future?
Coach Jason Kidd had initially painted a rosier picture, suggesting Irving could return in 2025. But as the season progressed, reality set in. In January, Kidd admitted, ‘When you’re coming back from an ACL, it’s a time thing… Mentally and physically, you want to be 100 percent.’ Wise words, but they also highlight the delicate balance between player health and team success. The Mavs, currently ranked 12th in the West with a 19-35 record, are already in rebuild mode after trading Anthony Davis to the Wizards. Sitting Irving for the rest of the season not only ensures his full recovery but also boosts their odds in the NBA draft lottery. With two first-round picks in the 2026 draft (their own and one from the Thunder), the Mavs could be setting the stage for a major turnaround—potentially building a powerhouse around Irving and rising star Cooper Flagg.
But let’s not forget the elephant in the room: Irving’s injury-prone history. Since joining the Mavs, he’s averaged 25.5 points per game, but his availability has been a constant question mark. Is this latest setback a sign of things to come, or will he finally return to his All-Star form next season? And here’s a thought-provoking question for you: Is the Mavs’ decision to prioritize Irving’s long-term health over short-term gains a smart move, or are they risking too much on a player with a history of injuries? Let us know in the comments—this is one debate that’s sure to spark some heated opinions!
